Drugs / KLA578-1
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07143318 | Jun 2025 → May 2026 overdue | — | Hunan Kelun Pharmaceutical Co., Ltd. | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | KLA578-1 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07143318 ↗ |
| Route | Intravenous | “Intravenous injection, single dose” NCT07143318 ↗ |